Sonnet BioTherapeutics Holdings Inc. (SONN) Fundamentals

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
SHARE INFORMATION
Market Cap$ 17,449,317
Shares Outstanding60,587,905
Float58,776,478
Percent Float97.01%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 483,626
Latest Fiscal EPS$ -1.02
Latest Fiscal Date2021-09-30
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions37
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months1,585,154
Institutional Holdings Percent16.8%
Institutional Sold Previous 3 Months1,258,427
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months-
Insider Holdings Percent2.5
Insider Sold Previous 3 Months-
Insider Shares Owned1,504,717
TRADING INFO
52 Week High$ 2.07
52 Week Low$ 0.23
52 Week High Change$ -71.76
21 Day Moving Average$ 0.2896
21 Day Extended Moving Average$ 0.286359
50 Day Moving Average$ 0.2759
50 Day Extended Moving Average$ 0.285251
200 Day Moving Average$ 0.369759
200 Day Extended Moving Average$ 0.470764
10 Day Average Volume371,811
20 Day Average Volume437,671
30 Day Average Volume419,104
50 Day Average Volume1,409,739
Alpha-0.090002
Beta0.1228
Standard Deviation0.167279
R20.001337
7 Day Price Change$ -0.002
7 Day Percent Change-0.69%
21 Day Price Change$ -0.021
21 Day Percent Change-6.8%
30 Day Price Change$ -0.0035
30 Day Percent Change-1.2%
Month to Date Price Change$ 0.0137
Month to Date Percent Change4.99%
Quarter to Date Price Change$ 0.008
Quarter to Date Percent Change2.86%
180 Day Price Change$ -0.0087
180 Day Percent Change-2.93%
200 Day Price Change$ -0.035
200 Day Percent Change-10.84%
Year to Date Price Change$ -0.1251
Year to Date Percent Change-30.28%

Sonnet BioTherapeutics Holdings Inc. (SONN) Key Ratios

PROFITABILITY
EBIT Margin-3,895.8%
EBITDA Margin-3,881.7%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin68.4%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 708,745
Revenue Per Share$ 0.0117
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.10
Total Debt To Equity0.00
Int Coverage-164.50
Current Ratio2.30
Leverage Ratio1.30
Quick Ratio2.10
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-0.50
Enterprise Value$ 4,015,315
Price to Sales24.62
Price to Free Cash-0.90
PE High Last 5 Years0.00
Price To Book2.10
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book2.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover19.50
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-247.02
Return on Equity-526.23
Return on Capital-502.79

Sonnet BioTherapeutics Holdings Inc. (SONN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOPankaj Mohan
Emplyoees9
Last AuditUE
CIK0001106838
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address100 Overlook Center
Suite 102
Princeton, NJ 8540
Websitehttps://www.sonnetbio.com
Facsimile+1 609 228-4330
Telephone+1 609 375-2227
Emailinfo@sonnetbio.com


Your Recent History
NASDAQ
SONN
Sonnet Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.